The highest analyst price target is $560.00 ,the lowest forecast is $511.00.
The average price target represents 72.62% Increase from the current price of $310.79.
Bio-Rad Laboratories's analyst rating consensus is a Strong Buy.
This is based on the ratings of 4 Wall Streets Analysts..
Bio-Rad Laboratories, Inc.
Class A Common Stock (BIO) Stock Price, Quote, News & History Nasdaq..
As a leading global provider of in-vitro diagnostics supplies, our diagnostic products and systems leverage a broad range of technologies and deliver high-value clinical information in the blood transfusion, diabetes monitoring, autoimmune, and infectious disease testing markets..
The name "Bio-Rad" is based on the words "biochemicals and radiochemicals," which described the company's first offerings.
However, instead of calling the company "Biochemical-Radiochemical Laboratories," the founders shortened it to simply Bio-Rad Laboratories..
Stock Price Forecast
The 5 analysts offering 12-month price forecasts for Bio Rad Laboratories Inc have a median target of 440.00, with a high estimate of 482.00 and a low estimate of 350.00.
The median estimate represents a +63.40% increase from the last price of 269.27..
Bio-Rad Laboratories's analyst rating consensus is a Strong Buy..
Shares of Bio-Rad Laboratories were trading lower in the after-hours market following the release of third-quarter financial results that showed the company swinging to a gain in the period but reporting lower sales from a year ago..
Shares of Bio-Rad Laboratories were trading lower in the after-hours market following the release of third-quarter financial results that showed the company swinging to a gain in the period but reporting lower sales from a year ago..
Visit a quote page and your recently viewed tickers will be displayed here.
Bio-Rad’s stock leads the S&P 500 decliners, as they suffer the biggest selloff in 36 years after disappointing results.
Bio-Rad Laboratories (BIO) to Post Q3 Earnings:
( NYSE:
Bio-Rad Products Browse Bio-Rad's products of life science research products and services for electrophoresis, imaging, PCR amplification, chromatography, sample prep, and more.
High-Quality Products that Advance Scientific Discovery & Improve Healthcare.
325 employees have rated Bio-Rad Laboratories Chief Executive Officer Norman Schwartz on Glassdoor.com.
Norman Schwartz has an approval rating of 84% among the company's employees.
What other stocks do shareholders of Bio-Rad Laboratories own? .
